Position in GILD
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$7,202,264
-$7,333,051 QoQ
Shares Held
57,007
-45.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#502
of 2,266 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $55,696,959 across 11 Drug Manufacturers - General names. GILD ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,248 | $18,683,766 | |
| 2 | LLY |
ELI LILLY & Co
|
8,310 | $9,967,264 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
57,007 | $7,202,264 | |
| 4 | MRK |
Merck & Co., Inc.
|
51,433 | $6,609,140 | |
| 5 | NVO |
Novo Nordisk A S
|
86,018 | $4,123,702 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,615 | $2,685,956 | |
| 7 | AMGN |
Amgen Inc
|
5,281 | $1,912,355 | |
| 8 | GSK |
GSK plc
|
24,289 | $1,273,229 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,202,264 | 57,007 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $14,535,315 | 104,293 | Shares | Sole | 2026-04-27 | |
| 2025-09-30 | $1,457,541 | 13,131 | Shares | Sole | 2025-10-31 | |
| 2024-03-31 | $1,935,924 | 26,429 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $535,071 | 6,605 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $854,629 | 11,089 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $1,561,990 | 25,320 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $1,185,285 | 16,324 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $1,789,877 | 25,993 | Shares | Sole | 2021-08-26 | |
| 2021-03-31 | $763,409 | 11,812 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||